🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 165 of 200 · A–Z by INN

  1. seladelpar lysine

    LIVDELZI

    ORAL FDA: approved

  2. seladelpar lysine dihydrate

    LYVDELZI (PREVIOUSLY SELADELPAR GILEAD)

    EMA: approved

    A05AX07

  3. selegiline

    ELDEPRYL Orion Laboratories Pty.

    TRANSDERMAL FDA: approved · TGA: approved

  4. selegiline hydrochloride

    ZELAPAR

    ORAL FDA: approved

  5. selenious acid

    SELENIOUS ACID Regeneron Ireland Designated Activity Company (DAC)

    SOLUTION FDA: approved

  6. selenium sulfide

    SELSUN Sanofi-aventis Healthcare Pty Ltd

    TOPICAL FDA: approved · TGA: approved

  7. selenomethionine se-75

    SELENOMETHIONINE SE 75

    INJECTION FDA: approved

  8. selexipag

    UPTRAVI Janssen-Cilag Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    B01AC27

  9. selinexor

    XPOVIO Shanghai Antengene Corporation Limited

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01XX66

  10. selpercatinib

    RETEVMO

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L01EX22

  11. selumetinib

    KOSELUGO Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

  12. selumetinib sulfate

    KOSELUGO

    ORAL FDA: approved

  13. semaglutide

    OZEMPIC NovoThirteen

    SOLUTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    A10BJ06

  14. semuloparin sodium

    MULSEVO

    EMA: application withdrawn

  15. semustine

    NMPA: clinical trials

  16. sennoside b

    SENOKOT Lacuna Pharma Pty Ltd

    TGA: approved

  17. sepetaprost

    SETANEO

    PMDA: approved

  18. sepiapterin

    SEPHIENCE PTC THERAPEUTICS, INC.

    ORAL FDA: approved · EMA: approved

    A16AX28

  19. sequence

    NMPA: clinical trials

  20. serelaxin

    REASANZ

    EMA: refused

    C01DX21

  21. sermorelin acetate

    GEREF

    INJECTION FDA: approved

  22. serplulimab

    HETRONIFLY

    EMA: approved · NMPA: clinical trials

    L01FF12

  23. sertaconazole nitrate

    ERTACZO

    TOPICAL FDA: approved

  24. sertraline

    ZOLOFT Viatris Pharmaceuticals Co.,

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources